1 results match your criteria: "Shanghai Jiaotong University Medical School Ruijin Hospital 200025[Affiliation]"
[Treatment outcome analysis of CTOP or CHOP regimen in newly diagnosed aggressive non-Hodgkin's lymphoma patients-results of a prospective, open, randomized, multicenter clinical trial].
Zhonghua Xue Ye Xue Za Zhi
October 2010
Shanghai Institute of Hematology, Shanghai Jiaotong University Medical School Ruijin Hospital 200025, China.
Objective: To compare the efficacy and toxicity of CTOP and CHOP regimen for newly diagnosed aggressive non-Hodgkin's lymphoma (NHL) patients.
Method: From Oct 2006 to Jun 2009, 196 patients enrolled into this clinical trial from 72 centers in China were randomized into CTOP or CHOP group.
Results: Of 154 patients evaluated, 105 assigned in CTOP group and 49 in CHOP.